Versantis AG

Versantis AG

Versantis AG

Date Founded



Technoparkstrasse 1,Zurich 8005

Type of Company


Employees (Worldwide)

1 - 10


IT Consulting & Services
Medical Support Services
Hospitals & Patient Services
Holding Companies

Company Description

Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland.

Executives & Employees

Chief Executive Officer & Director

Chief Operating Officer & Director

Board of Directors

Senior Vice President, Office of Technology at Mutual of America Life Insurance Co.

Senior Vice President-Global Transactions at Bayer Pharmaceuticals Corp.

Co-Founder & Partner at Redalpine Venture Partners AG

Chief Executive Officer & Director at Versantis AG

Advisor for Germany, Austria, Southern Switzerland & USA/Canada at Seventure Partners SA

Chief Operating Officer & Director at Versantis AG

Paths to Versantis AG
Potential Connections via
Relationship Science
Versantis AG
Details Hidden

RGPE is a venture capital/private equity investor through their firms and funds they manage.RGPE's WebCapital invests in the seed and early start-up phases of technology sector firms such as application software, security and biometrics. They look for firms with high value potential capable of becoming leaders in their market. They typically acquire a minority stake. Daily operations are left to the management team. They take a Board presence on of their portfolio firms. They invest a maximum of €500,000 in each transaction. They also structure co-investments with other funds or business angels. Exit strategies include flotation, third-party sales, MBOs, MBIs, OBOs.RGPE's Spinnaker firm invests at all stages of development: early, expansion, build-up and buyout. They focus on media sector investments such as production, distribution and a wide range of content presentations in addition to media enabling application technologies. RGPE is a minority shareholder. They seek high growth potential. They invest across Europe, particularly in Spain, Portugal, Italy and France. Typical investments range from €1 million to a maximum of €3.75 million.Through RGPE's Invercat Exterior FCR fund they invest primarily in Catalan firms as they expand into international markets. Initially the fund was promoted by the Catalan Government. Shares are held by major financial institutions in Spain.RGPE is responsible for the operational management of the Tirant Inversión venture capital fund. The fund, promoted by the Valencia Institute of Finances, is governed by the simplified scheme. Shares are held by institutional investors, private investors and family groups from the Valencia region. They focus on some early-stage investments with a particular focus on expansion capital. The fund invests primarily in firms in the Valencia region and also other geographic areas. While the fund is diversified, they seek to consolidate existing sectors and encourage growth in emerging sectors. They seek minority shares with a minimum investment of €1.5 million and a maximum of €8 million. They are present on the Boards of their portfolio firms.

Details Hidden

Esperante is an active manager which makes seed investments in start-up companies primarily in Europe and North America focusing on innovative human therapeutics for the treatment of major diseases and disorders.The firm seeks to invest in companies with a professional management team, therapeutic developments in major indications and which are generating revenue. They prefer to make syndicated investments with appropriate partners, investing up to EUR 500,000 per project per year and remaining open to follow-up financing in subsequent years.Esperante typically takes minority equity stakes and a seat on the board of directors of their investee companies, aiming to exit their investments within three to five years.

Details Hidden

Verve Capital Partners is an active manager which invests in European startups from a wide variety of industries and stages. It invests starting at CHF 10.000.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Versantis AG. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Versantis AG's profile does not indicate a business or promotional relationship of any kind between RelSci and Versantis AG.